HAVCR2 and breast cancer: These MDSCs facilitate BC progression and metastasis to lungs and lymph nodes, drive EMT via IL-6, and increase levels of immunosuppressive proteins (PD-1, PD-L1, LAG3, CTLA4, TIM-3) on T cells, contributing to their partial exhaustion mediated by IFN-γ (85).